Osterweis Capital Management’s Pulse Biosciences PLSE Stock Holding History

Osterweis Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.7K	Hold	1,000	–	–	﹤0.01%	212
2026 Q1	$21.6K	Hold	1,000	–	–	﹤0.01%	222
2025 Q4	$13.7K	Hold	1,000	–	–	﹤0.01%	281
2025 Q3	$17.7K	Hold	1,000	–	–	﹤0.01%	260
2025 Q2	$15.1K	Hold	1,000	–	–	﹤0.01%	268
2025 Q1	$16.1K	Hold	1,000	–	–	﹤0.01%	169
2024 Q4	$17.4K	Hold	1,000	–	–	﹤0.01%	188
2024 Q3	$17.5K	Hold	1,000	–	–	﹤0.01%	183
2024 Q2	$11.2K	Hold	1,000	–	–	﹤0.01%	191
2024 Q1	$8.71K	Hold	1,000	–	–	﹤0.01%	187
2023 Q4	$12.2K	Hold	1,000	–	–	﹤0.01%	185
2023 Q3	$4.03K	Hold	1,000	–	–	﹤0.01%	200
2023 Q2	$7.19K	Hold	1,000	–	–	﹤0.01%	204
2023 Q1	$3.36K	Hold	1,000	–	–	﹤0.01%	203
2022 Q4	$2.77K	Hold	1,000	–	–	﹤0.01%	228
2022 Q3	$2K	Buy	+1,000	New	+$1.62K	﹤0.01%	231

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Osterweis Capital Management's PLSE Position: Q2 2026 in Review

Osterweis Capital Management held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 1,000 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #212.

Osterweis Capital Management first reported a position in PLSE in Q3 2022 and has held it in 16 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Osterweis Capital Management held 1,000 shares of Pulse Biosciences worth $27.7K as of Q2 2026.
Osterweis Capital Management left its Pulse Biosciences share count unchanged in Q2 2026.
Pulse Biosciences made up ﹤0.01% of Osterweis Capital Management's portfolio in Q2 2026, its #212 holding.
Osterweis Capital Management first reported a position in Pulse Biosciences in Q3 2022 and has held it in 16 quarters since.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Osterweis Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.